696 related articles for article (PubMed ID: 14715868)
1. Phosphodiesterase 4 inhibition synergizes with relaxin signaling to promote decidualization of human endometrial stromal cells.
Bartsch O; Bartlick B; Ivell R
J Clin Endocrinol Metab; 2004 Jan; 89(1):324-34. PubMed ID: 14715868
[TBL] [Abstract][Full Text] [Related]
2. Relaxin and phosphodiesterases collaborate during decidualization.
Bartscha O; Ivell R
Ann N Y Acad Sci; 2004 Dec; 1030():479-92. PubMed ID: 15659833
[TBL] [Abstract][Full Text] [Related]
3. Progesterone-dependent decidualization of the human endometrium is mediated by cAMP.
Brar AK; Frank GR; Kessler CA; Cedars MI; Handwerger S
Endocrine; 1997 Jun; 6(3):301-7. PubMed ID: 9368687
[TBL] [Abstract][Full Text] [Related]
4. Activated protein kinase A is required for differentiation-dependent transcription of the decidual prolactin gene in human endometrial stromal cells.
Telgmann R; Maronde E; Taskén K; Gellersen B
Endocrinology; 1997 Mar; 138(3):929-37. PubMed ID: 9048592
[TBL] [Abstract][Full Text] [Related]
5. Relaxin and prostaglandin E(2) regulate interleukin 11 during human endometrial stromal cell decidualization.
Dimitriadis E; Stoikos C; Baca M; Fairlie WD; McCoubrie JE; Salamonsen LA
J Clin Endocrinol Metab; 2005 Jun; 90(6):3458-65. PubMed ID: 15784719
[TBL] [Abstract][Full Text] [Related]
6. Comparative studies on the in vitro decidualization process in the baboon (Papio anubis) and human.
Kim JJ; Jaffe RC; Fazleabas AT
Biol Reprod; 1998 Jul; 59(1):160-8. PubMed ID: 9675007
[TBL] [Abstract][Full Text] [Related]
7. Ligand activated relaxin receptor increases the transcription of IGFBP-1 and prolactin in human decidual and endometrial stromal cells.
Tang M; Mazella J; Zhu HH; Tseng L
Mol Hum Reprod; 2005 Apr; 11(4):237-43. PubMed ID: 15722441
[TBL] [Abstract][Full Text] [Related]
8. Endometrial stromal cells undergoing decidualization down-regulate their properties to produce proinflammatory cytokines in response to interleukin-1 beta via reduced p38 mitogen-activated protein kinase phosphorylation.
Yoshino O; Osuga Y; Hirota Y; Koga K; Hirata T; Yano T; Ayabe T; Tsutsumi O; Taketani Y
J Clin Endocrinol Metab; 2003 May; 88(5):2236-41. PubMed ID: 12727980
[TBL] [Abstract][Full Text] [Related]
9. KF19514, a phosphodiesterase 4 and 1 inhibitor, inhibits TNF-alpha-induced GM-CSF production by a human bronchial epithelial cell line via inhibition of PDE4.
Sasaki K; Manabe H
Inflamm Res; 2004 Jan; 53(1):31-7. PubMed ID: 15021978
[TBL] [Abstract][Full Text] [Related]
10. Action of rolipram on specific PDE4 cAMP phosphodiesterase isoforms and on the phosphorylation of cAMP-response-element-binding protein (CREB) and p38 mitogen-activated protein (MAP) kinase in U937 monocytic cells.
MacKenzie SJ; Houslay MD
Biochem J; 2000 Apr; 347(Pt 2):571-8. PubMed ID: 10749688
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PDE3B augments PDE4 inhibitor-induced apoptosis in a subset of patients with chronic lymphocytic leukemia.
Moon E; Lee R; Near R; Weintraub L; Wolda S; Lerner A
Clin Cancer Res; 2002 Feb; 8(2):589-95. PubMed ID: 11839681
[TBL] [Abstract][Full Text] [Related]
12. Type IV phosphodiesterase activity specifically regulates cAMP-stimulated casein secretion in the rat mammary gland.
Pooley L
Biochim Biophys Acta; 2002 Jun; 1590(1-3):84-92. PubMed ID: 12063171
[TBL] [Abstract][Full Text] [Related]
13. beta-Arrestin-mediated PDE4 cAMP phosphodiesterase recruitment regulates beta-adrenoceptor switching from Gs to Gi.
Baillie GS; Sood A; McPhee I; Gall I; Perry SJ; Lefkowitz RJ; Houslay MD
Proc Natl Acad Sci U S A; 2003 Feb; 100(3):940-5. PubMed ID: 12552097
[TBL] [Abstract][Full Text] [Related]
14. Type 4 cAMP phosphodiesterase (PDE4) inhibitors augment glucocorticoid-mediated apoptosis in B cell chronic lymphocytic leukemia (B-CLL) in the absence of exogenous adenylyl cyclase stimulation.
Tiwari S; Dong H; Kim EJ; Weintraub L; Epstein PM; Lerner A
Biochem Pharmacol; 2005 Feb; 69(3):473-83. PubMed ID: 15652238
[TBL] [Abstract][Full Text] [Related]
15. Selective up-regulation of phosphodiesterase-4 cyclic adenosine 3',5'-monophosphate (cAMP)-specific phosphodiesterase variants by elevated cAMP content in human myometrial cells in culture.
Méhats C; Tanguy G; Dallot E; Robert B; Rebourcet R; Ferré F; Leroy MJ
Endocrinology; 1999 Jul; 140(7):3228-37. PubMed ID: 10385419
[TBL] [Abstract][Full Text] [Related]
16. Phospholipase D1 as a key enzyme for decidualization in human endometrial stromal cells.
Yoon MS; Koo JB; Jeong YG; Kim YS; Lee JH; Yun HJ; Lee KS; Han JS
Biol Reprod; 2007 Feb; 76(2):250-8. PubMed ID: 17065600
[TBL] [Abstract][Full Text] [Related]
17. Identification of substrate specificity determinants in human cAMP-specific phosphodiesterase 4A by single-point mutagenesis.
Richter W; Unciuleac L; Hermsdorf T; Kronbach T; Dettmer D
Cell Signal; 2001 Mar; 13(3):159-67. PubMed ID: 11282454
[TBL] [Abstract][Full Text] [Related]
18. Regulation of distinct cyclic AMP-specific phosphodiesterase (phosphodiesterase type 4) isozymes in human monocytic cells.
Verghese MW; McConnell RT; Lenhard JM; Hamacher L; Jin SL
Mol Pharmacol; 1995 Jun; 47(6):1164-71. PubMed ID: 7603456
[TBL] [Abstract][Full Text] [Related]
19. Cyclic nucleotide phosphodiesterases (PDE) 3 and 4 in normal, malignant, and HTLV-I transformed human lymphocytes.
Ekholm D; Mulloy JC; Gao G; Degerman E; Franchini G; Manganiello VC
Biochem Pharmacol; 1999 Sep; 58(6):935-50. PubMed ID: 10509746
[TBL] [Abstract][Full Text] [Related]
20. Regulation of cyclic AMP in rat pulmonary microvascular endothelial cells by rolipram-sensitive cyclic AMP phosphodiesterase (PDE4).
Thompson WJ; Ashikaga T; Kelly JJ; Liu L; Zhu B; Vemavarapu L; Strada SJ
Biochem Pharmacol; 2002 Feb; 63(4):797-807. PubMed ID: 11992650
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
